Evaluating Single Use Technologies during Design Build of a Mammalian Cell Culture Facility


Mike Jenkins, General Manager at Catalent, disucsses the hurdles when adopting single-use technologies and how they got around them, from making the decision to sell their 'new' stainless steel bioreactors to a competitor and getting buy-in from internal stakeholders to move to disposable solutions.

He also explains the challenges that Catalent, also a CMO, experienced when working with clients around single-use technologies and the conventional apporach the organisation took  by seperating downstream and upstream innoculation areas by a physcial wall and air handlers - adapting to very high standards.



Have Your Say
Rate this feature and give us your feedback in the comments section below
To continue reading this story get free access